Therefore, identification of critical downstream genes that can substitute for Trp53 mutation and cooperate with oncogenic Kras to drive transformation can potentially lead to new insights into mechanisms of carcinogenesis, such as pathways by which Trp53 suppresses cancer. This evidence concerns the gene KRAS and cancer.